Adicet Bio Inc.

NASDAQ: ACET · Real-Time Price · USD
0.66
0.01 (1.57%)
At close: Aug 15, 2025, 2:59 PM

Adicet Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a 24.99M 9.73M
Cost of Revenue
6.47M 6.1M 5.01M n/a
Gross Profit
-6.47M -6.1M 24.99M 9.73M
Operating Income
-127.61M -152.04M -72.55M -61.43M
Interest Income
10.71M 9.95M 3.76M 91K
Pretax Income
-117.12M -142.66M -69.79M -62.12M
Net Income
-117.12M -142.66M -69.79M -62M
Selling & General & Admin
28.29M 26.53M 26.3M 22.22M
Research & Development
99.32M 106.04M 71.25M 48.94M
Other Expenses
n/a -6.1M n/a n/a
Operating Expenses
127.61M 126.48M 97.54M 71.16M
Interest Expense
4K n/a 80K 176K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
127.61M 132.58M 97.54M 71.16M
Income Tax Expense
n/a n/a -2.76M -125K
Shares Outstanding (Basic)
87.87M 43.04M 41.08M 30.95M
Shares Outstanding (Diluted)
87.87M 43.04M 41.08M 30.95M
EPS (Basic)
-1.33 -3.31 -1.7 -2
EPS (Diluted)
-1.33 -3.31 -1.7 -2
EBITDA
-110.65M -136.53M -64.7M -60.41M
EBIT
-117.12M -142.63M -69.71M -61.95M
Depreciation & Amortization
6.47M 6.1M 5.01M 1.54M